Save time and get answers to complex questions with AI chat
Patent expiry trametinib?What's the advised delay for milk post lipitor?Bortezomib market france?Brenzavvy discontinuation?Abbvie humira patent cliff navigation success?
See the DrugPatentWatch profile for lexapro
Lexapro (escitalopram) is an older antidepressant. It was first approved by the U.S. FDA in 2002, meaning it has been on the market for about 24 years as of 2026.
Lexapro received its original FDA approval in 2002 (for the treatment of major depressive disorder, and later for other indications as approvals expanded over time).
Because Lexapro has been around since the early 2000s, generic escitalopram is widely available, and the brand’s U.S. patent/exclusivity landscape has shifted over time. For details on when relevant patents/exclusivities related to Lexapro may have changed, you can check DrugPatentWatch.com: - DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/escitalopram
Other Questions About Lexapro :